JP2012092108A5 - - Google Patents

Download PDF

Info

Publication number
JP2012092108A5
JP2012092108A5 JP2011252115A JP2011252115A JP2012092108A5 JP 2012092108 A5 JP2012092108 A5 JP 2012092108A5 JP 2011252115 A JP2011252115 A JP 2011252115A JP 2011252115 A JP2011252115 A JP 2011252115A JP 2012092108 A5 JP2012092108 A5 JP 2012092108A5
Authority
JP
Japan
Prior art keywords
increased
composition
peptide
group
bioactive component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011252115A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012092108A (ja
JP5607013B2 (ja
Filing date
Publication date
Priority claimed from MYPI20003988A external-priority patent/MY134867A/en
Application filed filed Critical
Publication of JP2012092108A publication Critical patent/JP2012092108A/ja
Publication of JP2012092108A5 publication Critical patent/JP2012092108A5/ja
Application granted granted Critical
Publication of JP5607013B2 publication Critical patent/JP5607013B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2011252115A 2000-08-29 2011-11-17 ユウリコマロンギフォリアの生理活性フラクション Expired - Lifetime JP5607013B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MYPI20003988 2000-08-29
MYPI20003988A MY134867A (en) 2000-08-29 2000-08-29 Bioactive fraction of eurycoma longifolia

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2002522919A Division JP2004521075A (ja) 2000-08-29 2001-02-14 ユウリコマロンギフォリアの生理活性フラクション

Publications (3)

Publication Number Publication Date
JP2012092108A JP2012092108A (ja) 2012-05-17
JP2012092108A5 true JP2012092108A5 (enExample) 2013-05-02
JP5607013B2 JP5607013B2 (ja) 2014-10-15

Family

ID=19749476

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002522919A Pending JP2004521075A (ja) 2000-08-29 2001-02-14 ユウリコマロンギフォリアの生理活性フラクション
JP2011252115A Expired - Lifetime JP5607013B2 (ja) 2000-08-29 2011-11-17 ユウリコマロンギフォリアの生理活性フラクション

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2002522919A Pending JP2004521075A (ja) 2000-08-29 2001-02-14 ユウリコマロンギフォリアの生理活性フラクション

Country Status (7)

Country Link
EP (1) EP1313491B1 (enExample)
JP (2) JP2004521075A (enExample)
AU (1) AU2001247966A1 (enExample)
DE (1) DE60125955T2 (enExample)
DK (1) DK1313491T3 (enExample)
MY (1) MY134867A (enExample)
WO (1) WO2002017946A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004075901A2 (en) * 2003-02-25 2004-09-10 Mesko Charles A Compositon for increasing levels of hormones and a method for preparation of said composition
MY146000A (en) * 2006-08-07 2012-06-15 Univ Sains Malaysia Polar organic extract of eurycoma longifolia
KR100969325B1 (ko) * 2010-02-08 2010-07-09 인천대학교 산학협력단 홍조류로부터 비독성 자외선 차단용 추출물을 제조하는 방법 및 이를 이용한 비독성 자외선 차단제
CN102948569A (zh) * 2011-08-18 2013-03-06 顾立峰 东革阿里提取物及其应用
KR101413643B1 (ko) * 2012-12-12 2014-07-04 (주) 닥터코스텍 유리코마 롱기폴리아 추출물을 함유하는 화장료 및 이의 제조 방법
WO2014148883A1 (en) * 2013-03-20 2014-09-25 Natureceuticals Sdn Bhd Herbaceutical formulations
JP6683897B1 (ja) * 2018-08-21 2020-04-22 日本たばこ産業株式会社 深部体温低下剤
US11058737B2 (en) 2018-10-29 2021-07-13 Biotropics Malaysia Berhad Use of Euycoma longifolia extract in alleviating symptoms and/or conditions associated with hormonal imbalance in females
CN109456418B (zh) * 2019-01-17 2020-10-27 齐齐哈尔大学 一种活性东革阿里多糖及制备方法

Similar Documents

Publication Publication Date Title
NZ759512A (en) Delayed release compositions of linaclotide
HRP20171175T1 (hr) Novi triciklički spojevi
EP2121546A4 (en) PROCESS FOR THE PREPARATION OF ALPHA, OMEGA-DICARBOXYLIC ACID DERIVATIVES BY METATHESIS
JP2011168603A5 (enExample)
WO2015040640A3 (en) An improved process for the preparation of tenofovir alafenamide or pharmaceutically acceptable salts thereof
RU2015146614A (ru) Конъюгированная вакцина на основе пептида антигена wt1
MX393384B (es) Adyuvantes sinteticos de glucopiranosil-lipido.
WO2015024668A3 (en) Respiratory syncytial virus (rsv) vaccine
HRP20190982T1 (hr) Peptidi i njihova uporaba
FR2962437B1 (fr) Derives d'imidazopyridine, leur procede de preparation et leur application en therapeutique
HK1198359A1 (en) Carrier-linked treprostinil prodrugs
NZ602111A (en) Extended release formulations of rasagiline and uses thereof
JP2008533007A5 (enExample)
IL209967A (en) Peptides capable of inducing cytotoxic lymphocyte (ctl), medicinal preparations containing them and their use and in vitro methods of inducing ctl
MX348393B (es) Polimorfo de rifaximina y proceso para la preparacion del mismo.
WO2013082535A3 (en) Controlled-release peptide compositions and uses thereof
JP2014533681A5 (enExample)
EP2762153A3 (en) Vaccine composition for mucosal administration
UA112764C2 (uk) Оптимізований синтез чистих, неполіморфних кристалічних жовчних кислот із заданим розміром частинок
WO2008104852A3 (en) Pharmaceutical compositions comprising adsorbate of fenofibrate
CA2922375C (en) Alpha-tea salt forms: compositions and uses for treating disease
PT2722322T (pt) Derivado de 1,3-di-oxo-indeno, seu sal farmaceuticamente aceitável ou isómero ótico, seu método de preparação, e composição farmacêutica contendo o mesmo como ingrediente ativo, antiviral
WO2011121607A3 (en) Rasagiline and its pharmaceutically acceptable salts
WO2012164575A3 (en) Amorphous ritonavir co-precipitated
EP2364967A3 (en) Process for preparation of rasagiline and salts thereof